Macquarie Group’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.08M | Sell |
7,780
-8,133
| -51% | -$2.2M | 0.01% | 531 |
|
|
2025
Q4 | $3.99M | Buy |
15,913
+1,685
| +12% | +$448K | 0.02% | 445 |
|
|
2025
Q3 | $4.08M | Buy |
14,228
+2,366
| +20% | +$634K | ﹤0.01% | 988 |
|
|
2025
Q2 | $3.11M | Sell |
11,862
-2,160
| -15% | -$526K | ﹤0.01% | 1091 |
|
|
2025
Q1 | $3.26M | Buy |
14,022
+1,467
| +12% | +$356K | ﹤0.01% | 1084 |
|
|
2024
Q4 | $2.14M | Buy |
12,555
+3,333
| +36% | +$765K | ﹤0.01% | 1173 |
|
|
2024
Q3 | $2.06M | Buy |
9,222
+570
| +7% | +$125K | ﹤0.01% | 1217 |
|
|
2024
Q2 | $1.76M | Buy |
8,652
+2,467
| +40% | +$502K | ﹤0.01% | 1269 |
|
|
2024
Q1 | $1.35M | Buy |
6,185
+2,963
| +92% | +$653K | ﹤0.01% | 1319 |
|
|
2023
Q4 | $733K | Sell |
3,222
-497
| -13% | -$104K | ﹤0.01% | 1431 |
|
|
2023
Q3 | $747K | Sell |
3,719
-3,029
| -45% | -$639K | ﹤0.01% | 1397 |
|
|
2023
Q2 | $1.4M | Sell |
6,748
-1,355
| -17% | -$263K | ﹤0.01% | 1282 |
|
|
2023
Q1 | $1.6M | Buy |
8,103
+629
| +8% | +$129K | ﹤0.01% | 1233 |
|
|
2022
Q4 | $1.51M | Hold |
7,474
| – | – | ﹤0.01% | 1294 |
|
|
2022
Q3 | $1.31M | Buy |
7,474
+155
| +2% | +$31.7K | ﹤0.01% | 1357 |
|
|
2022
Q2 | $1.47M | Sell |
7,319
-326
| -4% | -$69.5K | ﹤0.01% | 1394 |
|
|
2022
Q1 | $1.73K | Buy |
7,645
+98
| +1% | +$23K | ﹤0.01% | 1406 |
|
|
2021
Q4 | $2.04M | Sell |
7,547
-2,331
| -24% | -$577K | ﹤0.01% | 1371 |
|
|
2021
Q3 | $2.39M | Sell |
9,878
-265
| -3% | -$66.8K | ﹤0.01% | 1329 |
|
|
2021
Q2 | $2.4M | Buy |
10,143
+5,416
| +115% | +$1.23M | ﹤0.01% | 1360 |
|
|
2021
Q1 | $1.03M | Sell |
4,727
-668
| -12% | -$134K | ﹤0.01% | 1391 |
|
|
2020
Q4 | $944K | Buy |
5,395
+73
| +1% | +$12.6K | ﹤0.01% | 1329 |
|
|
2020
Q3 | $861K | Buy |
5,322
+1,179
| +28% | +$187K | ﹤0.01% | 1272 |
|
|
2020
Q2 | $591K | Sell |
4,143
-399
| -9% | -$55.2K | ﹤0.01% | 1316 |
|
|
2020
Q1 | $493K | Sell |
4,542
-236
| -5% | -$34K | ﹤0.01% | 1273 |
|
|
2019
Q4 | $694K | Buy |
4,778
+350
| +8% | +$50.5K | ﹤0.01% | 1330 |
|
|
2019
Q3 | $639K | Hold |
4,428
| – | – | ﹤0.01% | 1324 |
|
|
2019
Q2 | $658K | Sell |
4,428
-225
| -5% | -$31.4K | ﹤0.01% | 1307 |
|
|
2019
Q1 | $612K | Buy |
4,653
+928
| +25% | +$114K | ﹤0.01% | 1283 |
|
|
2018
Q4 | $405K | Sell |
3,725
-63,474
| -94% | -$8.5M | ﹤0.01% | 1324 |
|
|
2018
Q3 | $10M | Buy |
67,199
+2,910
| +5% | +$443K | 0.02% | 644 |
|
|
2018
Q2 | $9.91M | Sell |
64,289
-427
| -0.7% | -$64.5K | 0.02% | 642 |
|
|
2018
Q1 | $8.99M | Buy |
64,716
+62,272
| +2,548% | +$9.15M | 0.02% | 634 |
|
|
2017
Q4 | $372K | Sell |
2,444
-3,904
| -61% | -$516K | ﹤0.01% | 1534 |
|
|
2017
Q3 | $824K | Sell |
6,348
-59
| -0.9% | -$7.87K | ﹤0.01% | 1281 |
|
|
2017
Q2 | $848K | Buy |
6,407
+4,889
| +322% | +$599K | ﹤0.01% | 1211 |
|
|
2017
Q1 | $187K | Sell |
1,518
-461
| -23% | -$54.6K | ﹤0.01% | 1440 |
|
|
2016
Q4 | $219K | Sell |
1,979
-38,109
| -95% | -$4.23M | ﹤0.01% | 1423 |
|
|
2016
Q3 | $4.74M | Sell |
40,088
-24,630
| -38% | -$2.9M | 0.01% | 747 |
|
|
2016
Q2 | $7.24M | Buy |
64,718
+62,390
| +2,680% | +$6.71M | 0.01% | 792 |
|
|
2016
Q1 | $234K | Hold |
2,328
| – | – | ﹤0.01% | 1336 |
|
|
2015
Q4 | $247K | Hold |
2,328
| – | – | ﹤0.01% | 1304 |
|
|
2015
Q3 | $217K | Hold |
2,328
| – | – | ﹤0.01% | 1385 |
|
|
2015
Q2 | $242K | Hold |
2,328
| – | – | ﹤0.01% | 1414 |
|
|
2015
Q1 | $252K | Hold |
2,328
| – | – | ﹤0.01% | 1372 |
|
|
2014
Q4 | $216K | Hold |
2,328
| – | – | ﹤0.01% | 1400 |
|
|
2014
Q3 | $204K | Hold |
2,328
| – | – | ﹤0.01% | 1393 |
|
|
2014
Q2 | $205K | Sell |
2,328
-349
| -13% | -$30.2K | ﹤0.01% | 1437 |
|
|
2014
Q1 | $226K | Hold |
2,677
| – | – | ﹤0.01% | 1400 |
|
|
2013
Q4 | $210K | Buy |
2,677
+1,513
| +130% | +$129K | ﹤0.01% | 1397 |
|
|
2013
Q3 | $99K | Hold |
1,164
| – | – | ﹤0.01% | 1504 |
|
|
2013
Q2 | $100K | Buy |
+1,164
| New | +$96.6K | ﹤0.01% | 1456 |
|
Other funds holding LH
VCM
VPM
Macquarie Group's LH Position: Q1 2026 in Review
Macquarie Group reduced its Labcorp (LH) stake by 51% in Q1 2026, selling an estimated $2.2M and leaving 7,780 shares worth $2.08M. The position accounts for 0.01% of the portfolio, ranked #531.
Macquarie Group first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $10M in Q3 2018. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Macquarie Group held 7,780 shares of Labcorp worth $2.08M as of Q1 2026.
- Macquarie Group sold 8,133 Labcorp shares in Q1 2026, an estimated $2.2M.
- Labcorp made up 0.01% of Macquarie Group's portfolio in Q1 2026, its #531 holding.
- Macquarie Group first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
- Macquarie Group's Labcorp position peaked at $10M in Q3 2018.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.